These aforementioned results collectively demonstrated that CRKL was a functional effector of miR‐429 mediated erythropoiesis‐promoting effect, and miR‐429 promoted CML erythropoiesis by downregulating CRKL expression. The gene discussed is CRKL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.